Triple Hormone Combo May Boost Metabolism

A monomeric peptide comprised of GLP-1, GIP, and glucagon reduced body weight and diabetic complications in obese mice, Matthias Tschoep, MD, PhD, of Helmholtz Diabetes Center in Munich, and colleagues reported in Nature Medicine. "The triple-action produces exceptional results in rodent models of obesity and diabetes, reducing blood glucose levels, appetite, and body fat to baseline levels," Tschoep told MedPage Today. "This means major progress toward the ultimate goal of precision medicines that control metabolism by simultaneously mimicking multiple physiological signals."http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/49002